Literature DB >> 205191

Pseudolymphoma in renal allograft recipients.

W P Geis, S Iwatsuki, Z Molnar, J L Giacchino, R H Kerman, T S Ing, J E Hano.   

Abstract

Five renal transplant recipients exhibited giant systemic lymphadenopathy shortly after transplantation. Biopsy specimens did not show Hodgkin's lymphoma. Immunosuppression was continued in all patients. In contrast to the rapidly fatal course of malignant lymphoma in transplant recipients, adenopathy in these five patients has uniformly resolved. Patients have been observed for 6 to 15 months with no evidence of residual disease. Interval biopsy specimens are not malignant. Each patient received antithymocyte globulin from a single lot for 10 to 21 days after transplantation. During administration, T cell lymphocytes were suppressed to 5% of control values. When lymphadenopathy occurred, T cell values rebounded to 371% of control values. Toxoplasmosis titers as well as viral cultures of lymph node biopsy specimens were negative. These data indicate a benign course of this histologically malignant disease and suggest a lymphoblastic rebound phenomenon to antithymocyte globulin.

Entities:  

Mesh:

Year:  1978        PMID: 205191     DOI: 10.1001/archsurg.1978.01370160119020

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

1.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

Review 2.  Depressed immunity and the development of cancer.

Authors:  I Penn
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

Review 3.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.

Authors:  Ashok Jain; Mike Nalesnik; Jorge Reyes; Renu Pokharna; George Mazariegos; Michael Green; Bijan Eghtesad; Wallis Marsh; Thomas Cacciarelli; Paulo Fontes; Kareem Abu-Elmagd; Rakesh Sindhi; Jake Demetris; John Fung
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.